- About Us
- Our Story
- Our Products
- Our Science
- Our People
- Our Citizenship
-
Investors
- Reports and Filings
- Presentations
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Governance
- Investor Services
- Media
- Partners
- Canada
- Australia
- Germany
- India
- New Zealand
- China
- Netherlands
- Spain
- Contact Us
Business Pillars
As an integrated global pharmaceutical company, we operate through three core segments – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. These include our Biologics and Formulation businesses in branded and unbranded markets, our integrated drug discovery programmes with innovator companies, and manufacturing services offered to them. Our strengths include Chemical Synthesis, Formulation Development and Manufacturing, Clinical and Regulatory expertise, a robust global supply chain and strategic networks.
-
PHARMACEUTICAL SERVICES & ACTIVE INGREDIENTS
-
Global Generics
-
Proprietary Products